Hims & Hers Health falls as FDA issues unfavorable compounded GLP-1 decision
health
Hims & Hers Health (NYSE:HIMS) is down 7% in early morning trading after the U.S. FDA determined that there is no shortage of Eli Lilly's (LLY) GLP-1 medication tirzepatide, the active ingredient in its weight loss and type 2 diabetes therapies Zepbo Read more
Choir sings to raise awareness of mental health help
2024-12-23 BBC on MSN.com
Thousands of NHS hospital beds could be freed up if Health Secretary delivers 'rollout plan' for osteoporosis screening, study shows
2024-12-15 Daily Mail on MSN.com
Health Care Providers Should Prioritize Sex Talks With Youth Following Trump's Win | Opinion
2024-12-19 MSN
Philadelphia 76ers star Joel Embiid working through injuries and mental health struggles
2024-12-21 The Associated Press on MSN.com
Public health experts are warning of a 'quad-demic' this winter. Here's where flu, COVID, RSV, and norovirus are spreading
2024-12-18 Fortune on MSN.com
Georgia Kousoulou shares health update after three week old baby's 'long and stressful' hospital trip
2024-12-21 OK! Magazine UK
State sets aside nearly $4 million for child behavioral health providers
2024-12-17 The Santa Fe New Mexican
UAE's nationwide health insurance scheme to begin on January 1
2024-12-16 MSN
Neighborhoods initiative, public-health head lauded by county leaders
2024-12-21 ARLnow.com
What is the importance of gut health? Expert explains reasons behind rising awareness in 2025
2024-12-18 India TV
